resveratrol has been researched along with Schistosoma japonicum Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Chen, TT; Hu, Y; Liu, C; Peng, S; Shen, Y; Wang, Y; Xu, Y; Yin, J | 1 |
Chen, Y; Xiao, Z | 1 |
2 other study(ies) available for resveratrol and Schistosoma japonicum Infection
Article | Year |
---|---|
Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with
Topics: Actins; Animals; Collagen Type I; Collagen Type III; Liver Cirrhosis; Male; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Schistosoma japonicum; Schistosomiasis japonica | 2019 |
[Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice].
Topics: Animals; Drug Therapy, Combination; Female; Liver Cirrhosis; Male; Mice; Oxidative Stress; Praziquantel; Resveratrol; Schistosoma japonicum; Schistosomiasis japonica; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |